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A  unique  protein  component,  protein  AA, 1 has been isolated  from amyloid 
fibrils  deposited  in  secondary  amyloidosis  (1-4),  and  also  in  some  cases  of 
primary and myeloma- or macroglobulinemia-associated amyloidosis (5). Anti- 
sera to protein AA have been used to detect a related serum protein, SAA, which 
has been suggested to be a circulating precursor of the fibril protein (5-8). The 
observation that AA and SAA have identical N-terminal amino acid sequences 
(9),  whereas  SAA  has  a  mol  wt  (approximately  14,000  daltons)  about  50% 
greater  than  AA  (approximately  9,000  daltons)  (9-11)  is consistent  with  this 
suggestion. 
Protein  SAA  which  is  present  in  low concentration  in  normal  sera,  is  in- 
creased in concentration in sera from patients with amyloidosis and also in sera 
from patients with diseases known to predispose to amyloidosis (5-8). Very high 
levels of SAA have been reported during acute inflammatory episodes (8) and 
after the injection of endotoxin (12), a procedure known to induce experimental 
amyloidosis  (13-15).  These  observations suggest that  SAA  may be an  acute- 
phase reactant or,  alternatively,  a  normal  tissue constituent released into the 
circulation  as a  result of injury associated with the inflammatory response.  In 
the present study, evidence supporting the latter possibility has been obtained 
by employing  indirect  immunofluorescence  to  identify  SAA-like  material  in 
fibroblasts  grown  in  culture  and  in  cryostat  sections  of different  connective 
tissues. 
Materials  and  Methods 
Amyloid Fibril Proteins and Amyloid-Related Serum Protein SAA.  Alkali-degraded amyloid 
fibrils (DAM)  2 were prepared by treatment with 0.1 N NaOH and amyloid protein AA was isolated 
by gel filtration of guanidine-degraded  amyloid fibrils as  described in detail  elsewhere  (2,  5). 
* This work was supported by grants from Sigrid Juselius Foundation, the National Research 
Council for Medical Sciences,  Finland, by the Norwegian Research Council for Science and the 
Humanities,  Anders Jahre's Foundation  for the  Advancement of Science,  and the  Norwegian 
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2  Abbreviations  used  ~n this paper.  DAM,  alkali-degraded  amylold fibrils; HEF,  human em- 
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TAB, typhoid-paratyphoid A and B. 
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Amyloid-related serum protein SAA was isolated from strongly SAA-positive sera by gel filtration 
in 10% formic acid (9). 
Anti-SAA Antibodies.  Purified protein SAA was used for immunization of rabbits by intra- 
muscular  and  subcutaneous  injections in complete  Freund's  adjuvant.  The resulting  antisera 
precipitated SAA but not AA in double-diffusion tests.  However,  isolated protein AA or DAM 
completely  blocked  the  antiserum  reaction  with  SAA  in  absorption tests.  Purified  anti-SAA 
antibodies were obtained by immunoabsorption of anti-SAA antiserum using glutaraldehyde in 
solubilized SAA-pesitive sera (16). 
SAA-Positive Human  Sera.  Sera  from patients with chronic  inflammatory conditions  and 
from patients with amyloidosis were assayed for the presence of SAA by double diffusion against 
anti-SAA antiserum and quantitated by radial diffusion as previously described (6). These SAA- 
positive and negative sera were used in immunofluorescence inhibition assays. Serum from one of 
us (R.  A.) was also tested before and after typhoid-paratyphoid A  and B  (TAB) vaccination, a 
procedure which strongly stimulated SAA pred,uction (12). 
Human Tissues.  The fetal tissues used as substrates for the immunofluorescence assays were 
obtained from medical abortions performed during the first trimester of gestation. Adult tissues 
were obtained from various operations. 5-pro cryostat sections were prepared from tissue blocks 
snap frozen in isopentane cooled with liquid nitrogen. Sections were fixed in -20°C acetone for 20 
rain, washed in phosphate-buffered saline, and employed in the immunofluorescence assay (17). 
Cells  in  Tissue  Culture.  Fibroblasts  [human embryonal  fibroblasts  (HEF)]  were  prepared 
from human fetuses by treating small pieces of bedy wall tissue with 0.25% trypsin and incubating 
for 2 h  (17).  The cells were then washed in culture medium and plated.  Cells were maintained 
in secondary culture in medium RPMI 1640 supplemented with 10% fetal calf serum. 1 ×  108 cells 
were grown on culture dishes (20 cm  ~) containing small cover slips. The cover slips were harvested 
after 1-2 days of culture, fixed for 20 rain in -20°C acetone, and used in the immunofluorescence 
assay. The cells were identified as fibroblasts on morphological criteria and by a positive immuno- 
fluorescence  staining  reaction  with  anti-human  collagen  and  anti-human  fibroblast  surface- 
specific antiserum (17).  These fibroblast-specific antisera reacted with virtually all cells in the 
cultures. HeLa cells and Raji leukemia cells were grown and harvested under the same conditions. 
Normal human lymphocytes were isolated by Isopaque-Ficoll sedimentation (18). 
Irnmunofluorescence  Method.  Indirect immunofluorescence (IFL) was performed as described 
previously (17, 19). Purified sheep anti-rabbit IgG antibodies labeled with fluorescein isotbiocya- 
hate (fluorescein to protein molar ratio 2.3) were used at a protein concentration of about 10 ~tg of 
antibody protein/ml. Standard incubation and washing times were employed.  Controls for speci- 
ficity of staining reactions included normal rabbit sera, rabbit anti-fibroblast surface antiserum 
(17),  anti-collagen antiserum prepared by immunization of a  rabbit with collagen eluted from 
human fetal skin (20),  as well as human anti-reticulin antibodies (21, 22). These antisera did not 
show any reaction with SAA or AA in double diffusion. 
Specificity controls also  included absorptions of anti-SAA antiserum and purified anti-SAA 
antibodies with purified amyloid proteins, S/~A, and human sera with or without SAA activity 
detectable by double diffusion. Absorptions were performed by adding equal amounts of antiserum 
to serially diluted absorbing antigen and incubating at room temperature for 2 h. The absorbed 
antisera were used in a  final concentration four times that of the end-point titer. 
Results 
SAA-Like  Material  in Cultured Embryonal Fibroblasts  and Sections  from 
Various Connective  Tissues.  Anti-SAA gave  a  strong staining reaction with 
cultured  human  embryonal  fibroblasts.  Fibroblasts  from  four  fetuses  were 
tested  for up  to  30  passages,  and  in  all  cases  acetone-fixed  cells from these 
cultures  exhibited  a  uniform  perinuclear  fluorescence  (Fig.  la)  with  a  fine 
fibrillar appearance at higher magnification (Fig.  1 b); virtually all cells in the 
culture exhibited this staining reaction. In contrast, unfixed cells and parafor- 
maldehyde-fixed  cells  did  not  stain.  Adult  fibroblasts  were  also  used  as  a 
substrate for anti-SAA,  but this yielded a weaker reaction and, therefore, the 1338  AMYLOID-RELATED  PROTEIN  SAA 
Fro.  1.  (a)  Embryonal  fibroblasts  in  tissue  culture  demonstrating  fluorescence  after 
indirect immunofluorescent staining with anti-SAA. Acetone-fixed cells,  ×  1,500.  (b) Same 
fibroblast culture in higher magnification ( x  4,500). Note fine fibrillar cytoplasmic staining 
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embryonal fibroblasts were selected for the further study involving fibroblast 
cultures. In similar experiments, no immunofluorescence was observed with the 
following cell types: human erythrocytes, HeLa cells, peripheral blood lympho- 
cytes, or Raji lymphoid cells. Since the staining reaction appeared to be primar- 
ily  a  property  of fibroblasts,  sections  from  various  connective  tissues  were 
examined.  These  studies showed that anti-SAA antibodies also reacted with 
connective tissue fibrils in embryonal skin (Figs. 2 and 3a), and in many other 
organs  as  will  be  discussed  below.  Adult  connective  tissues  were  used  as 
substrate for anti-SAA in IFL staining. However, because of marked autofluo- 
rescence of elastic or collagen fibers and some nonspecific adherence of serum 
proteins,  it was difficult to interpret the results.  Therefore,  embryonal skin 
sections were selected for the specificity investigations together with embryonal 
fibroblasts. 
Specificity of the Anti-SAA Reaction with Skin Sections and Cultured Fibro- 
blasts.  The specificity of the reaction with anti-SAA was further investigated 
with a series of neutralization experiments. Neutralization of anti-SAA immu- 
nofluorescent staining was seen after absorption with various preparations of 
amyloid material (Figs. 3 a-c) including DAM, purified protein AA as well as 
purified protein SAA, and all human sera tested which were positive for SAA in 
double-diffusion tests  (Table I).  In contrast, no inhibition was seen with the 
fractions of degraded amyloid which did not contain protein AA, that is,  the 
material excluded from the Sephadex G-100 column (void volume material) (4), 
or with  most human sera  negative for SAA.  The finding of three  sera that 
inhibited the immunofluorescence but did not have SAA detectable in double 
diffusion probably  reflects  a  greater  sensitivity  of the  immunofluorescence 
technique.  Serum was obtained from one individual (R.  A.)  before and after 
TAB vaccination. The prevaccination serum was negative for SAA in double 
diffusion and failed to inhibit the staining reaction. Serum obtained 24 h  after 
TAB  vaccination was  strongly positive for SAA  in  double diffusion and  in- 
hibited,  up  to a  dilution of 160, the immunofluorescence obtained with anti- 
SAA. Experiments were also performed that showed that the anti-SAA activity 
could be neutralized by absorptions with 50% suspension of fibroblasts. 
Studies with Purified Anti-SAA.  Purified anti-SAA antibodies prepared by 
immunoabsorption on  SAA-positive serum insolubilized with glutaraldehyde 
exhibited a  staining reaction on fetal skin sections and on cultured fibroblasts 
which was indistinguishable from the pattern obtained using whole anti-SAA 
antiserum as described above.  The staining reactions with purified anti-SAA 
were also completely abolished after absorption with purified protein AA and 
isolated protein SAA in concentrations similar to those required to neutralize 
the activity of the anti-SAA antiserum. 
Distribution of SAA-Like Material in Various Tissues.  Reaction with anti- 
SAA  antiserum  was  seen  with  connective tissue  fibrils in  many organs.  A 
random distribution of fine fibrils was  seen particularly in  loose connective 
tissue. Thin twisted fibrils were seen in close association with connective tissue 
cells (Fig. 2). Fibrils giving a positive staining reaction were well developed in 
subepithelial connective tissue forming a  network of fibrils of different diame- 
ters. Thin fibrils were just visible, whereas thick fibrils had a diameter of up to 
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Fio.  2.  Fibroblasts in loose connective tissue located in deep dermal layer exhibit short 
fibrillar fluorescent extensions. IFL staining of acetone-fixed cryostat sections with rabbit 
anti-SAA, x  1,500. 
Fibrils  were  observed  throughout  the  dermis,  both  in  the  papillary  and 
reticular parts. They had the same general orientation and occasionally formed 
parallel bundles and branching fibrils (Fig. 3 a). By using phase-contrast illumi- 
nation, fibrils reacting with  anti-SAA could be  distinguished (Fig.  3 b).  The 
pattern  of fluorescence seen with the  anti-SAA antiserum  was different from 
that obtained with rabbit anti-human  collagen and human  anti-reticulin anti- 
sera.  Anti-collagen antiserum  stained collagen fibers diffusely throughout the 
dermal connective tissue (Fig. 3 d) and no fine fibrils such as those seen with the 
anti-SAA were observed (Fig. 3a). 
FIG. 3.  (a)  Short fluorescent f;brils in the papillary dermis are contrasted to the long 
fibrils, up to 15 ~tm with the same general orientation in deeper layers. Epidermis (E} does 
not stain. Arrow points to fibril seen in Fig. 3 b with phase contrast. IFL as in Fig. 1. x 500. 
(b) Occasionally, fibrils corresponding to those stained by IFL can be seen in phase-contrast 
illumination.  Arrow points at fibril stained by anti-SAA in Fig. 3a. x  500. (c) Inhibition  of 
fibrillar anti-SAA staining reaction after absorption with SAA-positive serum. There is no 
fibrillar staining but lumpy precipitates can be seen (arrows) consistent with the antigen- 
antibody complexes formed because of the absorption. (d) Skin section stained with an anti- 
collagen antiserum against human fetal skin collagen.  Note massive staining in all layers 
of the dermis, but absence of fluorescence  in the epidermis. Both  fine coiled fibrils and 
larger collagen bundles are seen. IFL staining as described in legend of Fig. 1.  x  500. E.  LINDER,  R.  F.  ANDERS,  AND  J.  B.  NATVIG  1341 1342  AMYLOID-RELATED  PROTEIN  SAA 
TABLE  I 
Inhibition of Anti-SAA Antibody Activity with Amyloid Material and Amyloid-Related 
Serum Component, SAA 
Inhibitor 
Substrate for immunofluorescence reactions 
Skin sections  Cultured fibroblasts 
Amyloid fibril proteins 
DAM 
DAM fraction I (void volume material) 
Isolated protein AA 
Amyloid-related protein SAA 
Isolated protein SAA 
Serum with high SAA levels 
Serum with undetectable SAA levels 
10-30  ~g*  10-30  ~g 
1-3 ~g  3 ~tg 
2-6 ~g  6-8 ~g 
160-320  160 
* Indicates lowest concentration of micrograms per milliliter or highest serum dilution giving 
inhibition; (--), indicates no inhibition at 500/zg/ml or serum diluted 1/2. 
Anti-SAA produced a  fine fibrillar  fluorescence throughout  the  wall of the 
aorta (Fig. 4 a), and also stained fibrils in the walls of vessels of medium size and 
big arteries (Fig. 4 b). In contrast, capillaries and veins did not stain. In the lung 
strong specific fluorescence was seen in bronchial and bronchiolar walls in close 
relation to the basement membrane (Fig. 5a). This staining was much stronger 
than  the  weak reaction  seen in the  connective tissue between epithelial  ele- 
ments. In the liver, there was a faint staining of sinusoidal walls (Fig. 5 b), but 
no staining with hepatocytes or hematopoietic cells. In the kidney, some stain- 
ing was seen in the interstitium  and developing glomerular tufts (Fig. 5c). The 
distribution of staining in some tissues showed similarities with the distribution 
of elastic fibers. 
Discussion 
The results indicate that a  molecule antigenically related to protein SAA is 
produced by fibroblasts as identified by morphological criteria, as well as by the 
reaction  with  anti-collagen  and  anti-human  fibroblast surface-specific antise- 
rum (17). This protein SAA-related material is normally located as fine fibrils in 
connective tissues throughout the developing organism. This is consistent with 
the previous observation that  anti-amyloid  antibodies produced against  DAM 
reacted with fibroblasts in vitro (23). However, blocking experiments indicated 
that the staining reactions observed with anti-DAM were not due to only anti- 
AA antibodies (unpublished results) in spite of the monospecificity of anti-DAM 
for protein  AA in  the  double-diffusion assay  (4,  5).  This  suggests that  DAM 
preparations  contain  connective tissue  components,  unrelated  to protein  AA, 
which may not necessarily be integral components of the amyloid fibril. These 
difficulties could be avoided in  the  present  study in  which  antiserum  to the 
serum protein of SAA was used.  The specificity of the staining  obtained with 
this  reagent  was  demonstrated  by the  neutralization  obtained  with  isolated 
protein SAA, SAA-containing sera,  DAM, and isolated protein AA. 
Fibrils stained by anti-SAA were most abundant in the dermis. The fibers up 
to 15/~m in length, seemed to have the same general orientation. This suggests 
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Fro.  4.  (a) Cross-section of aorta wall with lumen (L) to the left (L) shows fluorescent 
fibrils in concentric layers of the muscular coat. IFL with anti-SAA, x  1,500. (b) Medium 
sized artery in developing kidney partly seen in tangential section (arrow). Fluorescent 
fibrils seem to form concentric rings in the vessel wall. The fibrils are cut longitudinally at 
the tangential section (arrow), obliquely at other sites. IFL with anti-SAA. ×  1,500. 
Fio.  5.  (a) Bronchiolar wall with bundles of fluorescent fibers with circular arrangement. 
Cross-section of fluorescent bundle at arrow. IFL with anti-SAA. ×  1,500. (b) Faint fibrillar 
staining reaction in walls of liver sinusoids. IFL as described in legend of  Fig. 1. ×  1,500. (c) 
Faint staining reaction in glomerular tuft. IFL as described in legend of Fig. 1.  ×  1,500. 
The distribution  of the antigen  was clearly distinct from the patterns  produced 
by anti-collagen antibodies  (20),  anti-reticulin antibodies (21,  22),  and antibod- 
ies to the connective  tissue SF antigen  of fibroblast origin (24).  Localization of 
the  SAA-like material,  for example  in  vessel walls,  corresponded  rather  well 
to  the  histochemical  staining  for elastin  (25).  However,  in the  fetal skin  only 
faint  histochemical  staining  corresponded  to  the  distribution  of fluorescence. 1344  AMYLOID-RELATED  PROTEIN  SAA 
The known amino acid composition and sequence data for SAA and AA  (1-3, 
9,  10) proteins show no relationship to elastin (26-28). However, a relationship 
to the microfibrillar component of the elastic fiber cannot be ruled out on the 
available  data  (27,  28).  A  possible  relationship  of amyloid fibril  proteins  to 
connective tissue microfibrils has been suggested previously (29).  Recently, a 
structural glycoprotein isolated from skin has been shown to form amyloid-like 
fibrils  in  vitro  (30).  This  protein  had  an  amino  acid  composition  which  was 
similar to that  of protein SAA and was found in higher  amounts in newborn 
than in adult skin (30). 
The fibrils reacting with anti-SAA antibodies varied slightly in appearance in 
different  tissues.  In  loose  connective  tissues  it  was  occasionally  possible  to 
observe fibrillar extensions of connective tissue cells. This is consistent with the 
staining of fibroblasts in vitro, even if extracellular fibrillar extensions could not 
be seen.  Apparently the staining reaction seen with fibroblasts in vitro repre- 
sents intracellular SAA-like material.  Lack of fibril formation in vitro does not 
necessarily indicate  that  the  secreted molecule does not form fibrils  in  vivo. 
This  has  been  shown  convincingly  in  the  case  of collagen  synthesis  where 
soluble procollagen molecules start to polymerize only after extracellular enzy- 
matic cleavage of terminal extension peptides (31). In this respect collagen and 
possibly the  SAA-like  material  differ  from  the  fibroblast  SF antigen  which 
forms  long  fibrillar  extensions  under  normal  tissue  culture  conditions  (32). 
Fibril formation may be a complex process influenced not only by enzymes in the 
medium but also by the presence of other macromolecules such as glycosamino- 
glycans (33) in developing connective tissues. 
The  structural  relationship  of the  connective tissue component observed in 
these studies to protein SAA and protein AA remains to be defined. The finding 
that  inhibitors  of protein  synthesis do not modify the  SAA response to endo- 
toxin  3 indicates  that  the  increase  in  the  concentration  of SAA  during  acute 
inflammatory episodes is not due to synthesis of SAA de novo. An alternative 
explanation in line with the observations reported here, is that SAA is released 
into the circulation by proteolysis from a larger precursor molecule. This may be 
the  connective  tissue  component  detected by the  immunofluorescent  studies 
documented here. 
Summary 
Protein SAA is a serum protein related to the major constituent of secondary 
amyloid fibrils,  protein  AA,  and has been suggested to be a  precursor of the 
amyloid protein AA. In the present study, the origin of SAA was investigated by 
studying  human  fetal  tissues  and  cultured  human  fetal fibroblasts  with  the 
indirect immunofluorescence technique.  Anti-SAA antibodies reacted strongly 
with  cultured  fibroblasts  producing  a  fine  fibrillar  cytoplasmic  staining  and 
with  extracellular  fibrils  in  loose  connective  tissues  and  vessel  walls.  The 
reactions were specifically inhibited by absorption with degraded amyloid mate- 
rial,  isolated protein  AA,  isolated protein  SAA,  and  sera from patients  with 
elevated levels of SAA. In contrast,  no inhibition  was seen with amyloid fibril 
3 Anders, R. F., and J. B. Natvig, Manuscript in preparation. E.  LINDER,  R.  F.  ANDERS,  AND  J.  B.  NATVIG  1345 
material  devoid  of  AA  protein  or  by  human  sera  in  which  SAA  was  not 
detectable by double-diffusion tests.  These observations showed that  SAA-like 
material is produced by fibroblasts and indicate that it is a normal constituent of 
developing extracellular connective tissue fibers. 
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